News
US FDA Names Agency Critic Vinay Prasad as Top Vaccine Official
(Reuters) -The U.S. Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized FDA leadership and COVID-19 mandates, as the director of its Center for Biologics Evaluation and Research, the agency said on Tuesday.
The study, published in the European Heart Journal, examined more than 1 million people aged 50 or older with data from 2012 ...
The Trump administration’s unprecedented $500 million grant for a broadly protective flu shot has confounded vaccine and ...
New Scientist on MSN21h
Shingles vaccine linked with lower risk of many common heart problemsShingles is associated with an increased chance of health problems like strokes and heart attacks, but receiving a shingles ...
NIH program to make vaccines against pathogens that can trigger pandemics uses approach pioneered in last century ...
Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...
The move follows Kennedy’s repeated statements about pharma-backed CDC advisory panels. The Health and Human Services Department has appointed a vaccine critic to review recent recommendations from an ...
FDA Commissioner Marty Makary on Tuesday named Indian-origin hematologist oncologist Vinay Prasad as the next director of the ...
These days, most people are vaccinated against measles, a highly contagious, life-threatening respiratory virus, when they ...
The project is funded by an unrestricted gift from a foundation known as Alumbra, established by philanthropist Christy ...
There's a vaccine for hepatitis B that, according to the CDC, can help to prevent millions of deaths worldwide.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback